EUVIMEDEUVIMED entdecken
Crossref

Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats

Lucie Ladislavová, Viera Kútná, Kristýna Mazochová, Klára Šíchová, Hynek Danda, Eva Lhotková, Libor Uttl, Vojtěch Brejtr, Kateřina Syrová, Vladimír Mazoch, Rachel Horsley, Tomáš Páleníček

Pharmacology Biochemistry and Behavior · 2026-10 · 267 · 174231

DOI: 10.1016/j.pbb.2026.174231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026-10. Verfasst von Lucie Ladislavová und 11 weiteren Autor:innen. Beteiligte Einrichtung: Psychedelics Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia. Electronic address: lucie.ladislavova@nudz…. Hauptthemen laut MEDLINE: Neurogenesis, Psilocybin, Behavior, Animal, Hallucinogens. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Ministry of Health of the Czech Republic, Czech Science Foundation, Univerzita Karlova v Praze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psilocin (4-hydroxy-N, N-dimethyltryptamine) is a substituted tryptamine alkaloid and a nonselective serotonergic agonist acting predominantly at 5-HT2A/C receptors, with substantial binding to 5-HT1A and 5-HT2B receptors. Microdosing is the practice of taking a very small, sub-perceptual dose, typically 5% to 10% of a full recreational dose, to improve mood, creativity, and focus without hallucinogenic effects. However, rigorous preclinical evidence for its behavioral and neurobiological effects remains limited. We therefore examined whether chronic psilocin microdosing alters behavior and dentate gyrus (DG) cell proliferation in adult male Wistar rats. Psilocin was administered subcutaneously at 0.05 or 0.075 mg/kg. Animals received six doses of psilocin or saline on alternate days over 18 days prior to the first behavioral assessment, and microdosing on alternate days continued between behavioral tasks for five weeks. To minimize acute drug effects, all behavioral assessments were performed 48 h after the preceding dose. Animals were tested sequentially in the Elevated Plus Maze, Hole-Board, Open Field, Social Interaction, and modified Forced Swim Test, with six-day intervals between tests. DG cell proliferation was quantified by BrdU and Ki-67 immunohistochemistry. Across this regimen, psilocin microdosing did not measurably affect locomotor activity, depressive-like behavior, sociability, or novelty seeking, and it did not increase DG proliferation by either marker. A small anxiogenic effect was detected in the Elevated Plus Maze. These data indicate that, under the present dosing schedule and endpoints, chronic psilocin microdosing produces limited behavioral effects and does not enhance hippocampal progenitor proliferation in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurogenesisPsilocybinBehavior, AnimalHallucinogensAnimalsMaleRats, WistarRatsCell ProliferationDentate GyrusDose-Response Relationship, DrugMaze Learning

Stichwörter der Autor:innen

AnxietyBehavioral testingDepressionHippocampal neurogenesisPsilocin microdosingSocial interactionWistar rats

Substanzen

PsilocybinpsilocinHallucinogens

Autor:innen und Institutionen

  • Psychedelics Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia. Electronic address: lucie.ladislavova@nudz.cz.
  • Department of Experimental Neurobiology, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia.
  • Psychedelics Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia.
  • Psychedelics Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague, 10, 100 00, Czechia.
  • Psychedelics Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia; Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University in Prague, Jugoslávských pa…
  • Psychedelics Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czechia; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague, 10, 100 00, Czechia. Electronic address: tomas.pa…

Förderung

  • Ministry of Health of the Czech Republic
  • Czech Science Foundation
  • Univerzita Karlova v Praze
  • Agentura Pro Zdravotnický Výzkum České Republiky

Zitieren

APA

Ladislavová, L., Kútná, V., Mazochová, K., Šíchová, K., Danda, H., Lhotková, E., Uttl, L., Brejtr, V., Syrová, K., Mazoch, V., Horsley, R., & Páleníček, T. (2026). Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats. Pharmacology Biochemistry and Behavior, 267, 174231. https://doi.org/10.1016/j.pbb.2026.174231

Vancouver

Ladislavová L, Kútná V, Mazochová K, Šíchová K, Danda H, Lhotková E, et al. Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats. Pharmacology Biochemistry and Behavior. 2026;267:174231. doi:10.1016/j.pbb.2026.174231

BibTeX
@article{Ladislavov2026,
  author = {Ladislavová, Lucie and Kútná, Viera and Mazochová, Kristýna and Šíchová, Klára and Danda, Hynek and Lhotková, Eva and Uttl, Libor and Brejtr, Vojtěch and Syrová, Kateřina and Mazoch, Vladimír and Horsley, Rachel and Páleníček, Tomáš},
  title = {Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2026},
  volume = {267},
  pages = {174231},
  doi = {10.1016/j.pbb.2026.174231}
}
Kostenlos starten →